What set me off on this rant was the very first comment on the piece that posted on January 31st, “Looking Backward – And a Peek in the Other Direction.” Here’s the comment: “Thanks, Doc. Hope you will comment on the news out of Israel this week: https://www.jpost.com/HEALTH-SCIENCE/A-cure-for-cancer-Israeli-scientists-say-they-think-they-found-one-578939” Naturally, I looked, and what I found […]
Putting the name of this imperious disease in the title of my homily places a weighty responsibility on me. Who am I to attempt to put forth relevant information and sensible opinions on this topic, the mere mention of which makes most normal folk distinctly uneasy? But I probably pay more attention to […]
Cancer Care: Where Are We and Where Are We Headed?
[ed note: Michael Jorrin is a longtime medical writer (not a doctor) who covers health and medical topics and trends for our readers, generally without an investment thesis. His words are his own, enjoy!] In the Doc Gumshoe blog about cancer that appeared in June of 2013 (you can check it out here), I commented […]
What’s Happening in Cancer Treatment? Are We Making Progress, or Are We Stuck?
Today we’re sharing another piece from our medical contributor, “Doc Gumshoe” — we have added the stock tickers to the companies he mentions for your researching convenience, but this survey of the state of cancer research — which will hopefully be good background help to folks trying to understand the basic science behind pitches for […]
Comments
Hi, I started following KSS here, and moved over to BioPub as well. I have substantial positions in over a dozen of his...
Oncolytics Biotech® Announces Presentation at the Society for Immunotherapy of Cancer 2018 Annual Meeting Showcasing Up...
Wow, very encouraging data for oncolytic H-1 parvovirus + avastin + PD1 combo in #Glioblastoma at #SNO18 78% ORR: 22% C...
$ONCY Dr. Annels, et al., will present pelareorep data at #SITC2018 showcasing upregulation of PD-L1 expression with reo...
Oncolytics Biotech® Announces Abstract for ASH Annual Meeting & Exposition Demonstrating Pelareorep Increases PD-L1 Exp...
$ONCY > OV's have shown an ability to turn cold tumors hot. We believe pelareorep will in mBC and excited to start work...
Pvt company: StemImmune. Vaccinia as oncolytic virus play. To cut to the chase, this company is too tentative and specul...